Charles Explorer logo
🇬🇧

Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial

Publication at Faculty of Science, Faculty of Physical Education and Sport, First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine |
2022

Abstract

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly being used for circulatory support in cardiogenic shock patients, although the evidence supporting its use in this context remains insufficient. The aim of the Extracorporeal

Membrane Oxygenation in the Therapy of Cardiogenic Shock (ECMO-CS) trial was to compare immediate implementation of VA-ECMO vs. an initially conservative therapy

(allowing downstream use of VA-ECMO) in patients with rapidly deteriorating or severe cardiogenic shock .